{
    "title": "115_hr2900",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Synthetic Drug Prevention, \nTreatment, and Education Act''.\n\nSEC. 2. SYNTHETIC RECREATIONAL DRUGS.\n\n    Title III of the Public Health Service Act is amended by inserting \nafter section 317T of such Act (42 U.S.C. 247b-22) the following:\n\n``SEC. 317U. SYNTHETIC RECREATIONAL DRUGS.\n\n    ``(a) Study.--Not later than 1 year after the date of enactment of \nthe Synthetic Drug Prevention, Treatment, and Education Act, the \nDirector of the Centers for Disease Control and Prevention (in this \nsection referred to as the `Director') shall--\n            ``(1) complete a study on strategies for preventing and \n        treating the use of synthetic recreational drugs (as identified \n        pursuant to subsection (b)(3)), including best rehabilitation \n        practices; and\n            ``(2) submit a report to the Congress on the results of \n        such study.\n    ``(b) Database.--\n            ``(1) In general.--The Secretary, in coordination with the \n        Administrator of the Drug Enforcement Administration, shall \n        establish and maintain a database of synthetic recreational \n        drugs.\n            ``(2) Availability.--The Secretary shall make the \n        information in the database under paragraph (1) publicly \n        available for use in preventing and treating the use of \n        synthetic recreational drugs.\n            ``(3) Identification of synthetic recreational drugs.--\n        Beginning not later than 90 days after the date of the \n        enactment of the Synthetic Drug Prevention, Treatment, and \n        Education Act, for purposes of this section, the Secretary \n        shall specify (and update as necessary) a list of substances, \n        each of which shall satisfy the following criteria:\n                    ``(A) The substance is an analogue of a controlled \n                substance (as defined in section 102 of the Controlled \n                Substances Act).\n                    ``(B) The substance is not marketed as a drug (as \n                defined in section 201 of the Federal Food, Drug, and \n                Cosmetic Act).\n                    ``(C) The substance is determined by the Secretary \n                to be marketed for recreational human use, irrespective \n                of claims to the contrary in the labeling and promotion \n                of the substance.\n        Each substance identified on the most recent list specified by \n        the Secretary pursuant to this paragraph is referred to in this \n        section as a `synthetic recreational drug'.\n    ``(c) Cannabimimetic Agents.--\n            ``(1) Outreach campaign.--Not later than 1 year after the \n        date of enactment of the Synthetic Drug Prevention, Treatment, \n        and Education Act, the Director, in collaboration with the \n        Assistant Secretary for Mental Health and Substance Use, the \n        Director of the National Institute on Drug Abuse, the Director \n        of the National Institutes of Health, and the Administrator of \n        the Drug Enforcement Administration, shall develop and \n        implement a national outreach campaign to educate law \n        enforcement personnel, State and local agencies, health care \n        professionals, community health organizations, parents, youth, \n        and other community members about preventing and treating the \n        use of cannabimimetic agents.\n            ``(2) Grants.--\n                    ``(A) In general.--The Director may make grants to \n                Federally-qualified health centers for programs to \n                increase public awareness about, and prevent and treat, \n                the use of cannabimimetic agents.\n                    ``(B) Partnership.--A Federally-qualified health \n                center receiving a grant under subparagraph (A) for a \n                program, may, to the extent such program is with \n                respect to increasing awareness about, or preventing, \n                the use of cannabimimetic agents, partner with a \n                recipient of grant under section 1032 of the National \n                Narcotics Leadership Act of 1988 (21 U.S.C. 1532) to \n                carry out such elements of the program.\n                    ``(C) Maximum amount.--The maximum amount of a \n                grant under this section shall be $250,000.\n                    ``(D) Authorization of appropriations.--To carry \n                out this paragraph, there is authorized to be \n                appropriated $5,000,000 for the period of fiscal years \n                2018 through 2020.\n    ``(d) Definitions.--In this section:\n            ``(1) The term `cannabimimetic agent' has the meaning given \n        to that term in section 202(d)(2) of the Controlled Substances \n        Act.\n            ``(2) The term `Federally-qualified health center' has the \n        meaning given to such term in section 1861(aa) of the Social \n        Security Act.''."
}